bioRxivImmunologyPreprint
TCF-7 is dispensable for the anti-tumor response but required for the persistent function of mature CD8 T cells
R. Harris, M. Mammadli, S. Hiner, Q. Yang, J. M. Sen, M. Karimi
Abstract
T Cell Factor-1, encoded by TCF-7, is a transcription factor that plays an essential role during T cell development and differentiation. In this manuscript we utilized a pre-clinical model provided evidence that TCF-7 is dispensable for the anti-tumor response, and that TCF-7 suppresses key transcriptional factors Eomes and T-bet and molecules responsible for peripheral CD8 T cell cytolytic function. We discovered that TCF-7 regulates NKG2D expression on naive and activated mouse CD8 T cells, and that peripheral CD8 T cells from TCF-7 cKO utilize NKG2D to clear tumor cells. We also provide evidence that TCF-7 regulates key signaling molecules, including LCK, LAT, ITK, PLC-{gamma}1, P65, ERKI/II, and JAK/STATs required for peripheral CD8 T cell persistent function. Our data transcriptomic and protein data uncovered the mechanism of how TCF-7 impacting peripheral CD8 T cell inflammatory cytokine production, CD8 T cell activation, and apoptosis. Our pre-clinical model showed that CD8 T cells from TCF-7 cKO mice did not cause GVHD, but effectively cleared primary tumor cells.
- organism: mouse
- assay: proteomics
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TGF-b/TIF1g signaling restrains CD8+ T cell expansion while preserving cytotoxic competence
Jesus Daniel Zambrano-Romero, Eugenio Contreras-Castillo, … Paula Licona Limon·bioRxiv·Nov 6, 2026
- Pre-division TCF1 drop determines long-term CD8 T cell fates
Natalie R. Favret, Maider Astorkia, … Mary Philip·bioRxiv·Oct 6, 2025
- HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells
C. Yerinde, J. Keye, … C. Weidinger·bioRxiv·Sep 18, 2022
- A lymphoid tissue chemokine checkpoint prevents loss of CD8+ T cell functionality
Lukas M. Altenburger, Daniela Claudino Carvoeiro, … Jens Volker Stein·SciencePeer-reviewed·Apr 30, 2026
- T cell-specific loss of IRF1 results in defective CD8 T cell activation and antitumor immunity
Lulu Shao, Hridesh Banerjee, … Saumendra N. Sarkar·bioRxiv·May 18, 2026
- Ly6C defines a subset of memory-like CD27+ γδ T cells with inducible cancer-killing function
R. Wiesheu, S. C. Edwards, … S. B. Coffelt·bioRxiv·Sep 8, 2020